Harvey Mamon: Dana-Farber Plans New Radiation Oncology Residency for 2028
Harvey Mamon/LinkedIn

Harvey Mamon: Dana-Farber Plans New Radiation Oncology Residency for 2028

Harvey Mamon, Radiation Oncologist at Dana-Farber Cancer Institute, Associate Professor of Radiation Oncology at Harvard Medical School, and Vice Chair for Education of the proposed Harvard Joint Center Radiation Oncology Residency Program, shared on LinkedIn: 

“To My Radiation Oncology Colleagues:

With the changes in the Boston hospital affiliations, we have applied to the ACGME to create a new residency based at the DFCI in affiliation with BIDMC and Children’s Hospital, bringing back the spirit of the JCRT.

The ACGME will be reviewing the application in early January.

If approved, we are planning on a compressed application and interview process in late January and February for current 4th year medical students to apply, with the first class starting in July 2028.

More information is available here.”

About the New Radiation Oncology Residency at Dana-Farber

Dana-Farber Cancer Institute, in collaboration with Beth Israel Deaconess Medical Center (BIDMC) and Boston Children’s Hospital, is developing the Harvard Joint Center Radiation Oncology Residency Program, a new Harvard-affiliated training initiative in Boston.

The programme aims to prepare future radiation oncologists through multidisciplinary clinical training, research opportunities, mentorship and exposure to advanced cancer treatments. Its educational model emphasizes scientific innovation, patient-centered care and collaboration across participating institutions.

The proposal comes as Dana-Farber develops a new clinical partnership with BIDMC, reshaping cancer care delivery and training relationships across Boston’s medical institutions.

Harvey Mamon: Dana-Farber Plans New Radiation Oncology Residency for 2028